ILUMYA

PI:
Carlos Wambier, PhD, MD

Sponsor:
Sun Pharma

Study Phase:
Investigator Initiated

Indicated For:
Moderate to Severe Psoriasis (age 35 or older)

Study Drug:
Injection – administered at Study Visits

Inclusion Criteria:
This study is for patients 35 years of age or older with moderate to severe psoriasis ands are willing to go on ILUMYA for the first time to manage the symptoms of psoriasis. Patients are also needed for this study that have psoriasis, and will not be going on ILUMYA for a one time blood draw at the beginning of the study.

Status:
Enrolling Soon/ accepting potential subjects for pre-screening

Compensation:
All eligible patients will be compensated for their time and travel to attend study visits.